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Background
PPS is a syndrome, which manifests with pleuropericar-
dial inflammation and occurs in about 15-20% of patients
undergoing surgery, involving the pleura, pericard or
both. The pathogenesis of the syndrome is not yet fully
understood. Carriage of MEFV mutations may explain
the occurrence of this syndrome, which largely overlaps
with FMF, in only part of the operated population.
Goal
To determine whether MEFV mutation carriage may
precipitate PPS or affect its phenotype.
Methods
86 patients who underwent cardiac surgery were studied,
45 of whom developed PPS (study group) and 41 have
not (control group). Demographic data (gender, age,
region of residence, ethnic origin) and type of surgery
were collected. The severity of PPS was evaluated, based
on a predefined scale. Genetic analysis determining car-
riage of one of the three most common MEFV gene
mutations (M694V, V726A, E148Q) was performed.
Results
The rate of women was higher in the PPS group
(p=0.001). No significant differences were found between
the 2 groups with regards to the rate of mutation car-
riage. Subgroup analysis for age, ethnic origin and gender
also failed to yield significant results. The severity of the
PPS in carriers was lower compared to non carriers.
Conclusions
Carriage of MEFV mutations does not predispose for
the development of PPS. However carriage of MEFV
mutations does affect PPS phenotype (P<0.05).
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